Real-world effectiveness and safety of low-dose tirzepatide in Japanese people with type 2 diabetes: a multicenter, retrospective, single-arm, observational study-East Shizuoka Tirzepatide (ESTATE) study
Endocrine Journal
The paper
Tatsuya Iwamoto, Nozomu Yamasaki, Shuko Nojiri, Collaborators of East Shizuoka Tirzepatide study
Show 11 more authors
Wataru Urasaki, Katsumi Aso, Katsutoshi Komatsu, 尚子 榎沢, Marie Kanzaki, Daisuke Takarabe, Jo Nagakura, Ken Sato, Naoaki Ito, Hirotaka Watada, Takashi Nomiyama,Juntendo University Shizuoka Hospital
Endocrine Journal · 29 Sep 2026